Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation

Gabriele Hoermannsperger, Thomas Clavel, Micha Hoffmann, Caroline Reiff, Denise Kelly, Gunnar Loh, Michael Blaut, Gabriele Hölzlwimmer, Melanie Laschinger, Dirk Haller

Research output: Contribution to journalArticle

54 Citations (Scopus)
4 Downloads (Pure)

Abstract

BACKGROUND: Clinical and experimental studies suggest that the probiotic mixture VSL#3 has protective activities in the context of inflammatory bowel disease (IBD). The aim of the study was to reveal bacterial strain-specific molecular mechanisms underlying the anti-inflammatory potential of VSL#3 in intestinal epithelial cells (IEC). METHODOLOGY/PRINCIPAL FINDINGS: VSL#3 inhibited TNF-induced secretion of the T-cell chemokine interferon-inducible protein (IP-10) in Mode-K cells. Lactobacillus casei (L. casei) cell surface proteins were identified as active anti-inflammatory components of VSL#3. Interestingly, L. casei failed to block TNF-induced IP-10 promoter activity or IP-10 gene transcription at the mRNA expression level but completely inhibited IP-10 protein secretion as well as IP-10-mediated T-cell transmigration. Kinetic studies, pulse-chase experiments and the use of a pharmacological inhibitor for the export machinery (brefeldin A) showed that L. casei did not impair initial IP-10 production but decreased intracellular IP-10 protein stability as a result of blocked IP-10 secretion. Although L. casei induced IP-10 ubiquitination, the inhibition of proteasomal or lysosomal degradation did not prevent the loss of intracellular IP-10. Most important for the mechanistic understanding, the inhibition of vesicular trafficking by 3-methyladenine (3-MA) inhibited IP-10 but not IL-6 expression, mimicking the inhibitory effects of L. casei. These findings suggest that L. casei impairs vesicular pathways important for the secretion of IP-10, followed by subsequent degradation of the proinflammatory chemokine. Feeding studies in TNF(DeltaARE) and IL-10(-/-) mice revealed a compartimentalized protection of VSL#3 on the development of cecal but not on ileal or colonic inflammation. Consistent with reduced tissue pathology in IL-10(-/-) mice, IP-10 protein expression was reduced in primary epithelial cells. CONCLUSIONS/SIGNIFICANCE: We demonstrate segment specific effects of probiotic intervention that correlate with reduced IP-10 protein expression in the native epithelium. Furthermore, we revealed post-translational degradation of IP-10 protein in IEC to be the molecular mechanism underlying the anti-inflammatory effect.
Original languageEnglish
Article numbere4365
Number of pages17
JournalPloS ONE
Volume4
Issue number2
DOIs
Publication statusPublished - 2009

Fingerprint

Intestinal Secretions
Lactobacillus casei
Probiotics
probiotics
Bacteria
epithelial cells
inflammation
Epithelial Cells
Inflammation
bacteria
Anti-Inflammatory Agents
T-cells
Proteins
Chemokines
Degradation
Interleukin-10
secretion
chemokines
interleukin-10
anti-inflammatory activity

Keywords

  • animals
  • autophagy
  • bacterial Proteins
  • chemokine CXCL10
  • chemotaxis
  • chronic disease
  • colitis
  • epithelial cells
  • humans
  • inflammation
  • intestines
  • intracellular space
  • Lactobacillus casei
  • lysosomes
  • mice
  • organ specificity
  • probiotics
  • protein processing, post-translational
  • signal transduction
  • transcription, genetic
  • tumor necrosis factor-alpha

Cite this

Hoermannsperger, G., Clavel, T., Hoffmann, M., Reiff, C., Kelly, D., Loh, G., ... Haller, D. (2009). Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PloS ONE, 4(2), [e4365]. https://doi.org/10.1371/journal.pone.0004365

Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria : impact on chronic inflammation. / Hoermannsperger, Gabriele; Clavel, Thomas; Hoffmann, Micha; Reiff, Caroline; Kelly, Denise; Loh, Gunnar; Blaut, Michael; Hölzlwimmer, Gabriele; Laschinger, Melanie; Haller, Dirk.

In: PloS ONE, Vol. 4, No. 2, e4365, 2009.

Research output: Contribution to journalArticle

Hoermannsperger, G, Clavel, T, Hoffmann, M, Reiff, C, Kelly, D, Loh, G, Blaut, M, Hölzlwimmer, G, Laschinger, M & Haller, D 2009, 'Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation', PloS ONE, vol. 4, no. 2, e4365. https://doi.org/10.1371/journal.pone.0004365
Hoermannsperger, Gabriele ; Clavel, Thomas ; Hoffmann, Micha ; Reiff, Caroline ; Kelly, Denise ; Loh, Gunnar ; Blaut, Michael ; Hölzlwimmer, Gabriele ; Laschinger, Melanie ; Haller, Dirk. / Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria : impact on chronic inflammation. In: PloS ONE. 2009 ; Vol. 4, No. 2.
@article{52bae3f2c69147c794e3f55274652801,
title = "Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation",
abstract = "BACKGROUND: Clinical and experimental studies suggest that the probiotic mixture VSL#3 has protective activities in the context of inflammatory bowel disease (IBD). The aim of the study was to reveal bacterial strain-specific molecular mechanisms underlying the anti-inflammatory potential of VSL#3 in intestinal epithelial cells (IEC). METHODOLOGY/PRINCIPAL FINDINGS: VSL#3 inhibited TNF-induced secretion of the T-cell chemokine interferon-inducible protein (IP-10) in Mode-K cells. Lactobacillus casei (L. casei) cell surface proteins were identified as active anti-inflammatory components of VSL#3. Interestingly, L. casei failed to block TNF-induced IP-10 promoter activity or IP-10 gene transcription at the mRNA expression level but completely inhibited IP-10 protein secretion as well as IP-10-mediated T-cell transmigration. Kinetic studies, pulse-chase experiments and the use of a pharmacological inhibitor for the export machinery (brefeldin A) showed that L. casei did not impair initial IP-10 production but decreased intracellular IP-10 protein stability as a result of blocked IP-10 secretion. Although L. casei induced IP-10 ubiquitination, the inhibition of proteasomal or lysosomal degradation did not prevent the loss of intracellular IP-10. Most important for the mechanistic understanding, the inhibition of vesicular trafficking by 3-methyladenine (3-MA) inhibited IP-10 but not IL-6 expression, mimicking the inhibitory effects of L. casei. These findings suggest that L. casei impairs vesicular pathways important for the secretion of IP-10, followed by subsequent degradation of the proinflammatory chemokine. Feeding studies in TNF(DeltaARE) and IL-10(-/-) mice revealed a compartimentalized protection of VSL#3 on the development of cecal but not on ileal or colonic inflammation. Consistent with reduced tissue pathology in IL-10(-/-) mice, IP-10 protein expression was reduced in primary epithelial cells. CONCLUSIONS/SIGNIFICANCE: We demonstrate segment specific effects of probiotic intervention that correlate with reduced IP-10 protein expression in the native epithelium. Furthermore, we revealed post-translational degradation of IP-10 protein in IEC to be the molecular mechanism underlying the anti-inflammatory effect.",
keywords = "animals, autophagy, bacterial Proteins, chemokine CXCL10, chemotaxis, chronic disease, colitis, epithelial cells, humans, inflammation, intestines, intracellular space, Lactobacillus casei, lysosomes, mice, organ specificity, probiotics, protein processing, post-translational, signal transduction, transcription, genetic, tumor necrosis factor-alpha",
author = "Gabriele Hoermannsperger and Thomas Clavel and Micha Hoffmann and Caroline Reiff and Denise Kelly and Gunnar Loh and Michael Blaut and Gabriele H{\"o}lzlwimmer and Melanie Laschinger and Dirk Haller",
year = "2009",
doi = "10.1371/journal.pone.0004365",
language = "English",
volume = "4",
journal = "PloS ONE",
issn = "1932-6203",
publisher = "PUBLIC LIBRARY SCIENCE",
number = "2",

}

TY - JOUR

T1 - Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria

T2 - impact on chronic inflammation

AU - Hoermannsperger, Gabriele

AU - Clavel, Thomas

AU - Hoffmann, Micha

AU - Reiff, Caroline

AU - Kelly, Denise

AU - Loh, Gunnar

AU - Blaut, Michael

AU - Hölzlwimmer, Gabriele

AU - Laschinger, Melanie

AU - Haller, Dirk

PY - 2009

Y1 - 2009

N2 - BACKGROUND: Clinical and experimental studies suggest that the probiotic mixture VSL#3 has protective activities in the context of inflammatory bowel disease (IBD). The aim of the study was to reveal bacterial strain-specific molecular mechanisms underlying the anti-inflammatory potential of VSL#3 in intestinal epithelial cells (IEC). METHODOLOGY/PRINCIPAL FINDINGS: VSL#3 inhibited TNF-induced secretion of the T-cell chemokine interferon-inducible protein (IP-10) in Mode-K cells. Lactobacillus casei (L. casei) cell surface proteins were identified as active anti-inflammatory components of VSL#3. Interestingly, L. casei failed to block TNF-induced IP-10 promoter activity or IP-10 gene transcription at the mRNA expression level but completely inhibited IP-10 protein secretion as well as IP-10-mediated T-cell transmigration. Kinetic studies, pulse-chase experiments and the use of a pharmacological inhibitor for the export machinery (brefeldin A) showed that L. casei did not impair initial IP-10 production but decreased intracellular IP-10 protein stability as a result of blocked IP-10 secretion. Although L. casei induced IP-10 ubiquitination, the inhibition of proteasomal or lysosomal degradation did not prevent the loss of intracellular IP-10. Most important for the mechanistic understanding, the inhibition of vesicular trafficking by 3-methyladenine (3-MA) inhibited IP-10 but not IL-6 expression, mimicking the inhibitory effects of L. casei. These findings suggest that L. casei impairs vesicular pathways important for the secretion of IP-10, followed by subsequent degradation of the proinflammatory chemokine. Feeding studies in TNF(DeltaARE) and IL-10(-/-) mice revealed a compartimentalized protection of VSL#3 on the development of cecal but not on ileal or colonic inflammation. Consistent with reduced tissue pathology in IL-10(-/-) mice, IP-10 protein expression was reduced in primary epithelial cells. CONCLUSIONS/SIGNIFICANCE: We demonstrate segment specific effects of probiotic intervention that correlate with reduced IP-10 protein expression in the native epithelium. Furthermore, we revealed post-translational degradation of IP-10 protein in IEC to be the molecular mechanism underlying the anti-inflammatory effect.

AB - BACKGROUND: Clinical and experimental studies suggest that the probiotic mixture VSL#3 has protective activities in the context of inflammatory bowel disease (IBD). The aim of the study was to reveal bacterial strain-specific molecular mechanisms underlying the anti-inflammatory potential of VSL#3 in intestinal epithelial cells (IEC). METHODOLOGY/PRINCIPAL FINDINGS: VSL#3 inhibited TNF-induced secretion of the T-cell chemokine interferon-inducible protein (IP-10) in Mode-K cells. Lactobacillus casei (L. casei) cell surface proteins were identified as active anti-inflammatory components of VSL#3. Interestingly, L. casei failed to block TNF-induced IP-10 promoter activity or IP-10 gene transcription at the mRNA expression level but completely inhibited IP-10 protein secretion as well as IP-10-mediated T-cell transmigration. Kinetic studies, pulse-chase experiments and the use of a pharmacological inhibitor for the export machinery (brefeldin A) showed that L. casei did not impair initial IP-10 production but decreased intracellular IP-10 protein stability as a result of blocked IP-10 secretion. Although L. casei induced IP-10 ubiquitination, the inhibition of proteasomal or lysosomal degradation did not prevent the loss of intracellular IP-10. Most important for the mechanistic understanding, the inhibition of vesicular trafficking by 3-methyladenine (3-MA) inhibited IP-10 but not IL-6 expression, mimicking the inhibitory effects of L. casei. These findings suggest that L. casei impairs vesicular pathways important for the secretion of IP-10, followed by subsequent degradation of the proinflammatory chemokine. Feeding studies in TNF(DeltaARE) and IL-10(-/-) mice revealed a compartimentalized protection of VSL#3 on the development of cecal but not on ileal or colonic inflammation. Consistent with reduced tissue pathology in IL-10(-/-) mice, IP-10 protein expression was reduced in primary epithelial cells. CONCLUSIONS/SIGNIFICANCE: We demonstrate segment specific effects of probiotic intervention that correlate with reduced IP-10 protein expression in the native epithelium. Furthermore, we revealed post-translational degradation of IP-10 protein in IEC to be the molecular mechanism underlying the anti-inflammatory effect.

KW - animals

KW - autophagy

KW - bacterial Proteins

KW - chemokine CXCL10

KW - chemotaxis

KW - chronic disease

KW - colitis

KW - epithelial cells

KW - humans

KW - inflammation

KW - intestines

KW - intracellular space

KW - Lactobacillus casei

KW - lysosomes

KW - mice

KW - organ specificity

KW - probiotics

KW - protein processing, post-translational

KW - signal transduction

KW - transcription, genetic

KW - tumor necrosis factor-alpha

U2 - 10.1371/journal.pone.0004365

DO - 10.1371/journal.pone.0004365

M3 - Article

C2 - 19197385

VL - 4

JO - PloS ONE

JF - PloS ONE

SN - 1932-6203

IS - 2

M1 - e4365

ER -